Syngene International surges 9% on ICMR nod for its Covid-19 test kit

The product will be launched once it receives approval from the Central Drugs Standard Control Organisation (CDSCO) next.

Shares of Syngene International rallied nearly 9 per cent on the BSE on Thursday, a day after the company and HiMedia Laboratories, which have collaborated to manufacture ELISafe 19, an IgG based ELISA test kit for Covid-19, received the approval by the Indian Council of Medical Research (ICMR). 

At 09:52 AM, the stock was trading 8.4 per cent higher at Rs 491.85 on the BSE as compared to a 0.76 per cent rise in the S&P BSE Sensex at 38,483.48 levels. The stock had hit an all-time high of Rs 522 on August 26, 2020. 

The product will be launched